The Drugs for Neglected Diseases initiative (DNDi) is a not-for-profit medical research organization that discovers, develops, and delivers safe, effective, and affordable treatments for neglected people. DNDi is developing medicines for sleeping sickness, leishmaniasis, Chagas disease, river blindness, mycetoma, dengue, pediatric HIV, advanced HIV disease, cryptococcal meningitis, and hepatitis C. Its research priorities include children’s health, gender equity and gender-responsive R&D, and diseases impacted by climate change. Since its creation in 2003, DNDi has joined with industry, academia, government, and philanthropic partners across the globe to deliver 12 new treatments, saving millions of lives.
Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.
Read More
Investment
Supporting companies across the healthcare ecosystem with flexible funding models…
Read More
Portfolio Companies
Deerfield generally maintains a combined portfolio of more than 150 private and public investments across the life science, medical device, diagnostic, digital health and health service industries at all stages of evolution from start-up to mature company.
Read More View Portfolio Companies
Research Collaborations
Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.
Read More View Research Collaborations
Strategic Partners
As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and unique access to innovation.
Read More
Deerfield Foundation
The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.
Read More Meet the Foundation TeamFoundation Partners by Focus
Children's Health Diversity Initiatives Maternal Health View AllFounded Diversity Programs
Break into the Boardroom Fellowships Science to the Street (formerly Women in Science)
Cure Campus
Cure is a 12-story innovation campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.
Read More Join the Cure Email ListCure Programming
Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.
Events at the Cure
Deerfield Announces Strategic Collaboration with Peking Union School of Public Health to Advance Healthcare in China
New York, New York –October 17, 2016 – Deerfield announced today a strategic collaboration with the Peking Union School of Public Health (PUSPH) to advance healthcare in China. Deerfield and PUSPH will collaborate to address healthcare needs in China using PUSPH’s local expertise and Deerfield’s US and European experience. The collaboration aims at sharing its findings through peer-reviewed joint publications.
The collaboration will focus on areas such as medicine procurement, supply chain management, antibiotics misuse, and hospital service quality assessment.
Deerfield will work closely with the PUSPH Dean Dr. Yuanli Liu and Food and Drug Safety and Policy Research Director Dr. Jing Sun. Dr. Yuanli Liu founded the US-China Health Summit during his tenure at Harvard T.H. Chan School of Public Health prior to joining PUSPH. Over the years, he has been committed to creating direct discussion among policy makers, academic experts and business leaders to transform global healthcare.
Peking Union Medical College’s emphasis on preventive medicine and public health dates back to the 1920s, when John B. Grant chaired the Department of Public Health. The new Peking Union School of Public Health(PUSPH) was established in 2014, with a mission to improve the public health by conducting inter-disciplinary, innovative and translational research, informing policy, serving communities, and educating future public health leaders.
“It is our privilege to partner with Dr. Liu and the PUSPH to develop findings that can benefit the Chinese population and can also be shared globally to advance healthcare,” said Jim Flynn, Deerfield’s Managing Partner.“We look forward to a productive and innovative partnership.”
“We are excited to work with a health care expert like Deerfield that has the skills, broad based understanding and technical knowledge to help develop findings that can advance healthcare.” said Professor Yuanli Liu.
About PUSPH
PUSPH offers master and doctoral degrees in public health,epidemiology, social medicine and health management etc.
For more information, please visit http://www.cams.cn/sph/.
About Deerfield
Deerfield is an investment management firm committed to advancing healthcare through investment, information and philanthropy.
For more information, please visit www.deerfield.com
Contacts
Deerfield Management Company
Karen Heidelberger, 212-692-7140
[email protected]